Announcements, research commentary, and publications from Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Regen.MD. The releases below have been distributed nationally through EIN Presswire and featured on AP News.
-
October 12, 2026
Dr. Gurpreet Singh Padda, MD: Trial Suggests PRP May Delay Knee Replacement for Patients Already on the Surgical List
For World Arthritis Day: what a randomized trial in patients already on the knee replacement list shows, and what it does not.
In 90 patients with grade 3 to 4 knee osteoarthritis, two PRP injections lowered pain and improved function against cortisone and an anti-inflammatory. The authors called it a bridge to surgery, not cartilage regrowth, and Dr. Padda reports it that way.
Read the full release ›EIN Presswire ›
Distributed nationally via EIN Presswire.
-
September 28, 2026
Dr. Gurpreet Singh Padda, MD Publishes ‘The Angry Gut, Your First Brain’
The third volume of The Brain: the gut’s nervous system came first, and the brain in the skull is the later addition.
A 492-page book, written with Ami Michelle Grimes, that prints the measured figure when it disagrees with the famous one: an intestinal surface of about 32 square meters, not a tennis court. Thirty-three chapters, each filmed, each with a free technical supplement.
Read the full release ›AP News ›National Law Review ›EIN Presswire ›
Also carried by KTVI FOX 2 St. Louis, KOLR 10 Springfield, Columbia Daily Tribune, Springfield News-Leader, KSN/KODE Joplin, The Detroit News, Detroit Free Press, The Indianapolis Star, The Tennessean, Milwaukee Journal Sentinel, The Arizona Republic, Akron Beacon Journal, WGN-TV Chicago, PIX11 New York and WPRI 12 Providence, among more than 850 news sites.
-
September 21, 2026
Dr. Gurpreet Singh Padda, MD Discusses Alzheimer’s Research, Not Just Plaque
On World Alzheimer’s Day: a brain that lost power decades before anyone looked for plaque.
Glucose uptake falls decades early while ketone uptake holds, insulin competes with amyloid for the same clearing enzyme, and three B vitamins cut brain atrophy 53 percent in high-homocysteine patients. The argument is for measuring what is already measurable.
Read the full release ›AP News ›National Law Review ›EIN Presswire ›
Also carried by KTVI FOX 2 St. Louis and the Akron Beacon Journal.
-
July 23, 2026
New Book ‘The Starved Brain’ by Dr. Gurpreet Padda Reframes Dementia as a Metabolic Disease of Overnutrition
Cognitive decline as the “malnutrition of excess” — a brain overfed on calories yet starved of the materials it is built from.
Dr. Gurpreet Padda’s new book reframes dementia as a metabolic disease of overnutrition and presents a four-pillar, evidence-graded framework for prevention.
Read the full release ›AP News ›EIN Presswire ›
Distributed to 100+ media outlets via EIN Presswire.
-
July 20, 2026
FDA Advisory Committee Convenes on Peptides: Understanding What Reclassification Means
Why the regulatory shift makes physician oversight and laboratory-guided prescribing more important, not less.
As the FDA’s Pharmacy Compounding Advisory Committee reviews seven peptides, Dr. Padda explains what reclassification does and does not mean for patient safety.
Read the full release ›AP News ›EIN Presswire ›
Distributed to 450+ media outlets via EIN Presswire.
-
July 19, 2026
Patients Already on the Knee Replacement Waiting List Find Platelet-Rich Plasma Outperformed Cortisone and NSAIDs
A randomized trial finds two PRP injections outperformed cortisone and anti-inflammatories — including in blood chemistry.
A randomized trial in 90 ‘bone-on-bone’ knee osteoarthritis patients found two PRP injections beat cortisone and NSAIDs on pain, function, opioid use, and biomarkers.
Read the full release ›AP News ›EIN Presswire ›
Distributed to 600+ media outlets via EIN Presswire.
For more information, get our free guide to knee pain and treatment options.
Media inquiries: info@regen.md. For clinical questions, request a Clinical Evaluation.